Clinical Trial Update: A Study of IMAB362 in Japanese Subjects With Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma [NA]

View source ↗

Summary

Clinical trial update for IMAB362 (zolbetuximab) in Japanese patients with locally advanced or metastatic gastric or GEJ adenocarcinoma; the study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• IMAB362 (zolbetuximab)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Gastric Cancer, Gastro-esophageal Junction (GEJ) Cancer | NA | Status: COMPLETED